Henry N. Edmunds

Dr. Edmunds is currently acting as Chief Financial Officer of Sepragen. He also serves as President of Biopheresis. Previously, he served as Vice President and Chief Financial Officer of Prometheus, a pharmaceutical company. He also served as Vice President of Corporate Development and Chief Financial Officer of SangStat Medical Corporation, and as Director of Business development at Genencor, Inc. Dr. Edmunds received his Ph.D. in Biotechnology from the University of California, Berkeley and his M.B.A. from the Stanford School of Business.